Wed, March 30, 2022

Patrick Trucchio Maintained (VIR) at Strong Buy with Decreased Target to $200 on, Mar 30th, 2022

Patrick Trucchio of HC Wainwright & Co., Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Decreased Target from $300 to $200 on, Mar 30th, 2022.

Patrick has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 1 agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joel Beatty of "Baird" Upgraded from Sell to Hold and Decreased Target to $28 on, Thursday, March 3rd, 2022


This is the rating of the analyst that currently disagrees with Patrick


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $45 on, Monday, March 28th, 2022